GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO) » Definitions » Shiller PE Ratio

Biotest AG (XTER:BIO) Shiller PE Ratio : 165.60 (As of May. 26, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Shiller PE Ratio?

As of today (2024-05-26), Biotest AG's current share price is €41.40. Biotest AG's E10 for the quarter that ended in Mar. 2024 was €0.25. Biotest AG's Shiller PE Ratio for today is 165.60.

The historical rank and industry rank for Biotest AG's Shiller PE Ratio or its related term are showing as below:

XTER:BIO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 27.09   Med: 69.21   Max: 1075
Current: 165.97

During the past years, Biotest AG's highest Shiller PE Ratio was 1075.00. The lowest was 27.09. And the median was 69.21.

XTER:BIO's Shiller PE Ratio is ranked worse than
94.77% of 153 companies
in the Biotechnology industry
Industry Median: 34.13 vs XTER:BIO: 165.97

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biotest AG's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.740. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €0.25 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biotest AG Shiller PE Ratio Historical Data

The historical data trend for Biotest AG's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Shiller PE Ratio Chart

Biotest AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.21 - 641.57 - 226.62

Biotest AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 379.11 226.62 169.98

Competitive Comparison of Biotest AG's Shiller PE Ratio

For the Biotechnology subindustry, Biotest AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotest AG's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biotest AG's Shiller PE Ratio falls into.



Biotest AG Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biotest AG's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=41.40/0.25
=165.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest AG's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Biotest AG's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.74/125.0381*125.0381
=0.740

Current CPI (Mar. 2024) = 125.0381.

Biotest AG Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.223 99.543 0.280
201409 0.137 99.823 0.172
201412 -0.013 99.543 -0.016
201503 0.037 99.717 0.046
201506 -0.090 100.417 -0.112
201509 -2.170 100.417 -2.702
201512 0.120 99.717 0.150
201603 0.050 100.017 0.063
201606 0.140 100.717 0.174
201609 -0.230 101.017 -0.285
201612 -1.130 101.217 -1.396
201703 -0.620 101.417 -0.764
201706 0.150 102.117 0.184
201709 -0.120 102.717 -0.146
201712 0.465 102.617 0.567
201803 0.670 102.917 0.814
201806 4.010 104.017 4.820
201809 0.130 104.718 0.155
201812 -0.243 104.217 -0.292
201903 -0.040 104.217 -0.048
201906 0.070 105.718 0.083
201909 -0.130 106.018 -0.153
201912 -0.056 105.818 -0.066
202003 -0.280 105.718 -0.331
202006 -0.160 106.618 -0.188
202009 -0.390 105.818 -0.461
202012 0.000 105.518 0.000
202103 -0.370 107.518 -0.430
202106 -0.110 108.486 -0.127
202109 -0.260 109.435 -0.297
202112 -0.897 110.384 -1.016
202203 -0.130 113.968 -0.143
202206 -0.390 115.760 -0.421
202209 -0.370 118.818 -0.389
202212 0.053 119.345 0.056
202303 -0.530 122.402 -0.541
202306 0.550 123.140 0.558
202309 2.891 124.195 2.911
202312 0.975 123.773 0.985
202403 0.740 125.038 0.740

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biotest AG  (XTER:BIO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Biotest AG Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Biotest AG's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotest AG (XTER:BIO) Business Description

Traded in Other Exchanges
Address
Landsteinerstrasse 5, Dreieich, DEU, 63303
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.